Why diabetes matters in dementia studies. Excluding diabetes status masks regional mitochondrial DNA copy number changes in human hippocampus, amygdala, and cerebellum in Alzheimers disease
Kaikini, A.; Shi, A.; Francis, P.; Swerdlow, R. H.; Troakes, C.; Kennedy, J.; Hodgkinson, A.; Malik, A. N.
Show abstract
STRUCTURED ABSTRACTO_ST_ABSINTRODUCTIONC_ST_ABSDiabetes is a major risk factor for Alzheimers disease (AD), and both diseases involve mitochondrial dysfunction. We hypothesised that AD is associated with reduced mitochondrial DNA copy number (mtDNA-CN) in vulnerable brain regions, and that diabetes modifies these changes. METHODSPost-mortem hippocampus, amygdala, and cerebellum samples (N=66-77) from non-cognitively impaired (NCI) and AD donors, with and without diabetes, were analysed. mtDNA-CN was quantified by absolute quantification. RESULTSOverall, mtDNA-CN was lower in AD. However, stratification by diabetes revealed opposite changes: non-diabetic AD cases showed reduced mtDNA-CN, whereas diabetic cases showed higher mtDNA-CN across all regions irrespective of cognitive status. DISCUSSIONThese findings confirm multiregional loss of mtDNA-CN in the AD brain, most evident in the absence of diabetes. The functional significance of higher mtDNA-CN in the diabetic brain remains unclear, but evidence that diabetes can mask effects has important implications for dementia studies.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Regional interneuron transcriptional changes reveal pathologic markers of disease progression in a mouse model of Alzheimer's disease 95%
- Retinal tau phosphorylation in Alzheimer's disease: a mass spectrometry study 94%
- An interim exploratory biomarker analysis of a Phase 2 clinical trial to assess the impact of CT1812 in Alzheimers disease 94%
Similar papers in this journal
- Emergence of distinct and heterogeneous strains of amyloid beta as Alzheimer s disease progresses in Down syndrome 94%
- Circular RNA detection identifies circPSEN1 alterations in brain specific to Autosomal Dominant Alzheimer Disease 94%
- TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus 94%
Similar papers in this journal
- Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's disease 96%
- Low circulating choline, a modifiable dietary factor, is associated with the pathological progression and metabolome dysfunction in Alzheimers disease. 96%
- Tau phosphorylated at serine 356 is associated with Alzheimer's disease pathology and can be lowered in mouse and human brain tissue using the NUAK inhibitor WZ4003 95%
Similar papers in this journal
- Polygenic coronary artery disease association with brain atrophy in the cognitively impaired 95%
- Dementia is strongly associated with medial temporal atrophy even after accounting for neuropathologies 95%
- Alzheimer's disease biomarker profiling in a memory clinic cohort without common comorbidities 95%